摘要
目的为了解肠道病毒71型(EV71)和柯萨奇病毒A16型(CoxA16)在深圳市健康人群中的隐性感染情况,进一步探讨隐性感染在儿童手足口病(HFMD)中的传播特征及危害性。方法实验采用酶联免疫(ELISA)法检测不同年龄层(0~59岁之间)的健康人群血清中抗肠道病毒71型(EV71)和柯萨奇病毒A16型(CoxA16)的IgM和IgG抗体水平,并采用荧光定量PCR检测IgM阳性的样本中病毒核酸的阳性率。结果抗EV71和CoxA16 IgG抗体的阳性率都随着年龄段的增长呈下降趋势,0~5岁儿童组的IgG抗体阳性率最高,其中抗EV71的IgG抗体阳性率为79.7%,抗CoxA16的IgG抗体阳性率为91.93%。30岁以下者,两种病毒的抗体阳性率在70%以上,显著高于30岁以上人群,P<0.01。5岁以下儿童抗EV71抗IgM抗体阳性率达15.9%。49份抗EV71 IgM阳性样本中有42份EV71的核酸阳性,阳性率为85.7%;31份抗CoxA16 IgM阳性样本中有25份CoxA16核酸阳性样本,阳性率为80.6%。结论人群对EV71和CoxA16普遍容易感染,健康人群中存在较高的隐性感染,隐性感染率与人群的年龄分布存在相关性,因此隐性感染人群也是病原体传播的传染源之一。
Objective To investigate subclinical infection of enterovirus 71(EV71) and Coxsackievirus A16(CoxA16) in health population in Shenzhen and analyze the prevalent features and harmfulness of hand-foot-mouth disease(HFMD).Methods ELISA was used to detect the antibody against enterovirus71(EV71),Coxsackievirus A16(CoxA16) in healthy person aged from 0~59 years.Results The positive rate of IgG antibody against EV71 and CoxA16 decreased with the age growth,and the higest positive rate were in 0~5 year old group in which the IgG antibody against EV71 was 79.7% and the IgG antibody against CoxA16 was 91.93%.The positive rates of antibody to both viruses were above 70% in the adult below the age of 30 years,showing significant difference compared with that above age of 30 years(P0.01).The higest positive rate were in 0~5 year old group with IgM antibody against EV71 was 15.9%.Through real-time RT-PCR,42 out of 49 samples the IgM positive sera positive against IgM antibody were also positive for nucleic acid of EV71 with positive rate of 85.7% and 25 out of 31 positive sera positive against CoxA16 were also positive for nucleic acid of CoxA16 with the positive rate of 80.6%.Conclusion People are generally susceptible to EV71 and CoxA16 and there were subclinical infection with HFMD in healthy population.Subclinical infection of HFMD play very important role in transmition of HFMD.
出处
《中国热带医学》
CAS
2011年第11期1332-1333,共2页
China Tropical Medicine
关键词
手足口病
隐性感染
血清学分析
Hand-foot-mouth disease(HFMD)
Subclinical infection
Sera analysis.